GW Pharmaceuticals awaits FDA approval for Epidiolex, which contains an element derived from cannabis. It will treat children suffering from two rare forms of epilepsy by making their seizures less frequent.
GW Pharmaceuticals awaits FDA approval for Epidiolex, which contains an element derived from cannabis. It will treat children suffering from two rare forms of epilepsy by making their seizures less frequent.